White Paper

Upstream Viral Safety: A Holistic Approach To Mitigating Contamination Risks

Risk Decision

The safety of biologics from adventitious agents relies on a multilayered strategy that encompasses controlled manufacturing processes and the biomanufacturers’ implementation of risk mitigation strategies to prevent contamination. This holistic approach has delivered safe products for human use for many decades and continues to meet today’s expanding patient needs.

This whitepaper describes how different elements of viral safety can be integrated to minimize the risk of bioreactor contamination and the resulting disruption to biomanufacturing operations.

VIEW THE WHITE PAPER!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of BioProcess Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: